Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?
- 19 February 2007
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 39 (7) , 435-437
- https://doi.org/10.1038/sj.bmt.1705611
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimensArthritis & Rheumatism, 2006
- Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosisArthritis & Rheumatism, 2006
- Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerismArthritis & Rheumatism, 2004
- Defective vasculogenesis in systemic sclerosisThe Lancet, 2004
- Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR RegistryAnnals of the Rheumatic Diseases, 2004
- Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effectBone Marrow Transplantation, 2003
- In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationBlood, 2000
- Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritisExperimental Hematology, 2000
- Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient miceProceedings of the National Academy of Sciences, 1999